|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| C07K 19/00 | |||
| C07K 14/575 |
| (11) | Number of the document | 1718665 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05722892.6 |
| Date of filing the European patent application | 2005-02-11 | |
| (97) | Date of publication of the European application | 2006-11-08 |
| (45) | Date of publication and mention of the grant of the patent | 2013-04-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/004178 |
| Date | 2005-02-11 |
| (87) | Number | WO 2005/077072 |
| Date | 2005-08-25 |
| (30) | Number | Date | Country code |
| 543407 P | 2004-02-11 | US |
| (72) |
LEVY, Odile Esther, US
HANLEY, Michael R., US
JODKA, Carolyn M., US
LEWIS, Diana Y., US
SOARES, Christopher J., US
GHOSH, Soumitra S., US
D`SOUZA, Lawrence J., US
PARKES, David G., US
MACK, Christine M., US
|
| (73) |
Amylin Pharmaceuticals, LLC,
9360 Towne Centre Drive, San Diego, CA 92121,
US
AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE, US |
| (54) | HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES |
| HYBRID POLYPEPTIDES WITH SELECTABLE PROPERTIES |